New Hope for Preventing Spread and Treating Prostate Cancer

Prostate cancer is the second most common cancer in men in our country after lung cancer. Revolutionary advances have substantially reduced deaths from this disease: 5-year survival in localized prostate cancer exceeds %98. However, deaths remain numerous in prostate cancer that has spread throughout the body (metastatic). Preventing spread and progression would therefore represent one of the greatest revolutions in fighting prostate cancer. This article shares an important development in this area.
A study in America discovered that a molecule called DNA-PKcs is the main regulator of pathways causing prostate cancer to spread to distant tissues (metastasis). It was described as an important target for developing drugs to prevent spread in prostate and other cancers.
In cancer spread through blood, cells made more mobile by certain DNA abnormalities (mutations) enter the bloodstream, travel elsewhere in the body, attach and settle there, causing new tumor sites to develop.
DNA-PKcs is a repair enzyme responsible for repairing and rejoining damaged, broken DNA strands in the body. A recently published study found that it also tries to repair damaged cancer cells, preventing their destruction by the body . It was also more active in patients with hormone-resistant prostate cancer, suggesting a possible role in resistance to hormonal therapy. The research team states it has developed a drug blocking DNA-PKcs and clinical studies are ongoing. We will follow the study and certainly share its results when completed.
In conclusion, this study is an important development for preventing spread and treating prostate and other cancers. If effectiveness is clarified in coming years, measuring blood DNA-PKcs could help predict cancer spread early and take precautions before it happens. Drugs targeting this enzyme could also prevent and treat spread. However, its role in normal DNA repair as well as cancer spread creates a challenge for clinical use. If future studies overcome this difficulty, an important weapon for preventing and treating advanced disease will have been gained.
Sources
DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.
Cancer Cell, 13 July 2015. DOI: https://dx.doi.org/10.1016/j.ccell.2015.06.004
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.